Profil

De Voeght Adrien

GIGA I3 - Hematology

Département des sciences cliniques > GIGA

Département des sciences cliniques

See author's contact details
ORCID
0000-0003-3727-5190
Main Referenced Co-authors
Baron, Frédéric  (8)
E Silva, Bianca  (5)
Ehx, Grégory  (5)
Faville, Charline  (5)
Cobraiville, Gaël  (4)
Main Referenced Keywords
Acute myeloid leukemia (3); Cytarabine (2); Immunopeptidomics (2); Mass spectrometry (2); Acanthocytes (1);
Main Referenced Unit & Research Centers
GIGA I3-Hematology - ULiège (1)
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège (1)
Main Referenced Disciplines
Hematology (14)
Immunology & infectious disease (3)
General & internal medicine (2)
Anesthesia & intensive care (1)
Endocrinology, metabolism & nutrition (1)

Publications (total 23)

The most downloaded
11340 downloads
Delmotte, V., Foidart, P., DE VOEGHT, A., LEJEUNE, M., & Delwaide, J. (2019). Diagnostic différentiel de l’anémie dans la cirrhose éthylique. Revue Médicale de Liège, 74 (10), 527-534. https://hdl.handle.net/2268/242373

The most cited

26 citations (OpenAlex)

Pirnay, J.-P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., Wagemans, J., Lood, C., Schrevens, E., Chanishvili, N., Kutateladze, M., de Jode, M., Ceyssens, P.-J., Draye, J.-P., Verbeken, G., ... Guiot, J. (Other coll.). (2024). Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nature Microbiology. doi:10.1038/s41564-024-01705-x https://hdl.handle.net/2268/319367

De Voeght, A. (06 November 2024). Fungal Infections in Hematology [Paper presentation]. Joint Meeting SFMM – BSHAM.

Faville, C., E Silva, B., Cobraiville, G., Ehx, G., Fillet, M., Baron, F., De Voeght, A., Vilanova Mana, L., Willems, L., Baiwir, D., & Mazzucchelli, G. (October 2024). Optimization of an MHC-I immunoprecipitation protocol for mass spectrometry analyses of persister-specific antigens in acute myeloid leukemia [Paper presentation]. yBIS: 1st annual meeting.

Faville, C., E Silva, B., Vilanova Mana, L., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M., Mazzucchelli, G., Ehx, G., Baiwir, D., & Willems, L. (September 2024). Optimization Of An MHC-I immunoprecipitation Protocol For Mass Spectrometry Analyses Of Persister-Specific Antigens In Acute Myeloid Leukemia [Poster presentation]. GIGA Day.

Pirnay, J.-P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., Wagemans, J., Lood, C., Schrevens, E., Chanishvili, N., Kutateladze, M., de Jode, M., Ceyssens, P.-J., Draye, J.-P., Verbeken, G., ... Guiot, J. (Other coll.). (2024). Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nature Microbiology. doi:10.1038/s41564-024-01705-x
Peer Reviewed verified by ORBi

Dierickx, D., Connerotte, T., Dallemagne, J., De Becker, A., Moors, I., Snauwaert, S., Sonet, A., Theunissen, K., Breems, D., De Voeght, A., JASPERS, A., Lambert, C., Heyrman, B., Hautekiet, J., Lyna, S., Maertens, C., & Delrieu, V. (2024). Real-World Insights on the Management of Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) With Caplacizumab. Blood Vessels, Thrombosis and Hemostasis, 100008. doi:10.1016/j.bvth.2024.100008
Peer reviewed

MAQUET, C., DE PRIJCK, B., JASPERS, A., Tassin, F., Keutgens, A., Beguin, Y., & De Voeght, A. (May 2024). Front-line venetoclax monotherapy for blastic plasmacytoid dendritric cell neoplasm. Belgian Journal of Hematology, 15 (3), 125-129.
Peer Reviewed verified by ORBi

Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Poster presentation]. Télévie Seminar.
* These authors have contributed equally to this work.

Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Paper presentation]. Télévie Seminar.
* These authors have contributed equally to this work.

De Voeght, A. (02 February 2024). AML: new therapies - current and future [Paper presentation]. 39th General Annual Meeting of the Belgian Hematology Society 2024.

Pirotte, M., De Voeght, A., VERTENOEIL, G., Vasbien Myriam, Paridaens, H., Somja, J., Collins, P., & Lambert, F. (December 2023). VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, SOMATIC SYNDROME (VEXAS SYNDROME) WITH MULTIPLE THROMBOEMBOLISM EVENTS: A BELGIAN CASE REPORT. Belgian Journal of Hematology, 14 (8), 336–42.
Peer Reviewed verified by ORBi

De Voeght, A. (October 2023). MAGROLIMAB: A NEW WEAPON AGAINST CANCER CELLS. Belgian Journal of Hematology, 14 (6), 250–4.
Peer Reviewed verified by ORBi

E Silva, B., Faville, C., Jassin, M., DUBOIS, S., De Voeght, A., Baron, F., & Ehx, G. (09 September 2023). Characterizing the immune recognition of chemo-persister blasts in acute myeloid leukemia [Poster presentation]. GIGA Day 2023.

De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266
Peer Reviewed verified by ORBi

DE VOEGHT, A. (15 October 2021). Thrombotic Microvascular Injury is not Mediated by Thrombotic Micro Angiopathy Despite Systemic Complement Activation in COVID-19 Patients. Journal of Blood Disorders and Transfusion, 12.
Peer Reviewed verified by ORBi

DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475.
Peer reviewed

DE VOEGHT, A., CALMES, D., BECK, F., SYLVESTRE, J.-B., DELVENNE, P., PETERS, P., VERTENOEIL, G., BARON, F., LAYIOS, N., & CANIVET, J.-L. (2020). Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/256301.

DE VOEGHT, A., Godon, E., Chachati, A., CAVALIER, E., & Buysschaert, B. (2019). HYPERCALCÉMIE SUR INTOXICATION À LA VITAMINE D : VIGNETTE CLINIQUE ET REVUE DE LA LITTÉRATURE. Louvain Medical.
Peer reviewed

Delmotte, V., Foidart, P., DE VOEGHT, A., LEJEUNE, M., & Delwaide, J. (2019). Diagnostic différentiel de l’anémie dans la cirrhose éthylique. Revue Médicale de Liège, 74 (10), 527-534.
Peer reviewed

Schweich, M., DE VOEGHT, A., Sacre, F., BERNARD, V., & Michels, V. (2018). Scorbut, maladie historique ? Revue Médicale de Liège, 73:11, 541-543.
Peer reviewed

DE VOEGHT, A., Martens, H., RENARD, J. D. C., VAIRA, D., Debruche, M., Simonet, J., Geenen, V., MOUTSCHEN, M., & DARCIS, G. (2017). Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium. PLoS ONE. doi:10.1371/journal.pone.0185761
Peer Reviewed verified by ORBi

DE VOEGHT, A., Maes, N., & Moutschen, M. (27 March 2016). sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1 infected Africans living in Belgium. AIDS, 30 (6), 921-4. doi:10.1097/QAD.0000000000000996
Peer Reviewed verified by ORBi

DE VOEGHT, A., SAUVAGE, A.-S., GENSBURGER, M., GIOT, J.-B., & Moutschen, M. (2016). Tuberculose miliaire chez une patiente sous adalimumab. Revue Médicale de Liège, 71 (7-8), 328-331.
Peer reviewed

Pirotte, B., Rassenfosse, M., Collin, R., De Voeght, A., MOUTSCHEN, M., & CAVALIER, E. (2013). Rôle de la vitamine D dans l'infection par le VIH: revue des connaissances actuelles. Revue Médicale de Liège, 68 (1), 25-31.
Peer reviewed

Contact ORBi